Plan Group Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$789K Buy
12,796
+1,397
+12% +$88.3K 0.15% 98
2026
Q2
$657K Buy
11,399
+1,390
+14% +$79.8K 0.14% 114
2026
Q1
$607K Buy
10,009
+1,049
+12% +$61.2K 0.14% 117
2025
Q4
$483K Buy
8,960
+4,417
+97% +$212K 0.13% 120
2025
Q3
$205K Buy
+4,543
New +$212K 0.06% 176

Other funds holding BMY

Plan Group Financial's BMY Position: Q3 2026 in Review

Plan Group Financial increased its Bristol-Myers Squibb (BMY) stake by 12% in Q3 2026, buying an estimated $88.3K and bringing the position to 12,796 shares worth $789K. The position accounts for 0.15% of the portfolio, ranked #98.

Plan Group Financial first reported a position in BMY in Q3 2025 and has held it in 5 quarters since. 835 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Plan Group Financial held 12,796 shares of Bristol-Myers Squibb worth $789K as of Q3 2026.
  • Plan Group Financial bought 1,397 Bristol-Myers Squibb shares in Q3 2026, an estimated $88.3K.
  • Bristol-Myers Squibb made up 0.15% of Plan Group Financial's portfolio in Q3 2026, its #98 holding.
  • Plan Group Financial first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 5 quarters since.
  • 835 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Plan Group Financial's 13F filing for Q3 2026, filed 22 Oct 2026.